An international survey on the impact of COVID-19 in individuals with Down syndrome

Anke Hüls, Alberto C. S. Costa, Mara Dierssen, R. Asaad Baksh, Stefania Bargagna, Nicole T. Baumer, Ana Claudia Brandão, Angelo Carfi, Maria Carmona-Iragui, Brain Allen Chicoine, Sujay Ghosh, Monica Lakhanpaul, Coral Manso, Miguel-Angel Mayer, Maria del Carmen Ortega, Diego Real de Asua, Anne-Sophie Rebillat, Lauren Ashley Russell, Giuseppina Sgandurra, Diletta Valentini, Stephanie L Sherman, Andre Strydom on behalf of the T21RS COVID-19 Initiative
doi: https://doi.org/10.1101/2020.11.03.20225359

Article Information

doi 
https://doi.org/10.1101/2020.11.03.20225359
History 
  • November 5, 2020.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.

Author Information

  1. Anke Hüls, PhD1,
  2. Alberto C. S. Costa, MD*,2,
  3. Mara Dierssen, MD*,3,
  4. R. Asaad Baksh, PhD4,5,
  5. Stefania Bargagna, MD6,
  6. Nicole T. Baumer, MD7,
  7. Ana Claudia Brandão, MD8,
  8. Angelo Carfi, MD9,
  9. Maria Carmona-Iragui, MD10,11,
  10. Brain Allen Chicoine, MD12,
  11. Sujay Ghosh, PhD13,
  12. Monica Lakhanpaul, MD14,15,16,
  13. Coral Manso, MD17,
  14. Miguel-Angel Mayer, MD18,
  15. Maria del Carmen Ortega, MD19,
  16. Diego Real de Asua, MD20,
  17. Anne-Sophie Rebillat, MD21,
  18. Lauren Ashley Russell, BS21,22,
  19. Giuseppina Sgandurra, MD23,24,
  20. Diletta Valentini, MD25,
  21. Stephanie L Sherman, PhD#,26,
  22. Andre Strydom, MD#,27,28,29,† and
  23. on behalf of the T21RS COVID-19 Initiative
  1. 1Department of Epidemiology and Gangarosa Department of Environmental Health, Rollins School of Public Health, Emory University, Atlanta, Georgia, USA
  2. 2Departments of Pediatrics and of Psychiatry, School of Medicine, Case Western Reserve University, Cleveland, Ohio, USA
  3. 3Centre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Barcelona, Spain; Universitat Pompeu Fabra (UPF), Barcelona, Spain
  4. 4Institute of Psychiatry, Psychology, and Neuroscience, Department of Forensic and Neurodevelopmental Sciences, King’s College London, London, United Kingdom
  5. 5The London Down Syndrome (LonDownS) Consortium, London, United Kingdom
  6. 6Fondazione Stella Maris IRCCS, Pisa, Italy
  7. 7Boston Children’s Hospital and Harvard Medical School, Boston, MA, USA
  8. 8Hospital Israelita Albert Einstein, Sao Paulo, SP, Brazil
  9. 9Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy
  10. 10Sant Pau Memory Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain
  11. 11Barcelona Down Medical Center, Fundació Catalana de Síndrome de Down, Barcelona, Spain
  12. 12Advocate Medical Group Adult Down Syndrome Center, Park Ridge, IL, USA
  13. 13Cytogenetics and Genomics Reserach Unit. Department of Zoology, University of Calcutta.Kolkata. West Bengal, India
  14. 14UCL- Great Ormond Street Institute of Child Health, London, United Kingdom
  15. 15Whttington NHS Trust, London, United Kingdom
  16. 16Down Syndrome Medical Interest Group, London, United Kingdom
  17. 17DOWN ESPAÑA, Barcelona, Spain
  18. 18Research Programme on Biomedical Informatics (GRIB), Hospital del Mar Medical Research Institute and DCEXS Universitat Pompeu Fabra, Barcelona, Spain
  19. 19Department of Psychiatry, Research Institute i+12. Hospital Universitario 12 de Octubre. Madrid, Spain
  20. 20Department of Internal Medicine and Instituto de Investigación Biomédica-La Princesa, Hospital Universitario de La Princesa, Madrid, Spain
  21. 21Institut Jérôme Lejeune, Paris, France
  22. 22Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia, USA
  23. 23Department of Developmental Neuroscience, IRCCS Fondazione Stella Maris, Pisa, Italy
  24. 24Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy
  25. 25Pediatric Unit, Bambino Gesù Children’s Hospital, IRCCS, Rome, Italy
  26. 26Department of Human Genetics, School of Medicine, Emory University, Atlanta, Georgia, USA
  27. 27Institute of Psychiatry, Psychology, and Neuroscience, Department of Forensic and Neurodevelopmental Sciences, King’s College London, London, United Kingdom
  28. 28The London Down Syndrome (LonDownS) Consortium, London, United Kingdom
  29. 29South London and the Maudsley NHS Foundation Trust
  1. ↵†Corresponding author:
    Andre Strydom, MD, Institute of Psychiatry, Psychology, and Neuroscience, Department of Forensic and Neurodevelopmental Sciences, King’s College London, London, United Kingdom; The London Down Syndrome (LonDownS) Consortium, London, United Kingdom; South London and the Maudsley NHS Foundation Trust, andre.strydom{at}kcl.ac.uk, +44 20 7848 5701

  1. ↵*,# equal contribution

Back to top
Posted November 05, 2020.
Download PDF

Supplementary Material

Data/Code
Email
An international survey on the impact of COVID-19 in individuals with Down syndrome
Anke Hüls, Alberto C. S. Costa, Mara Dierssen, R. Asaad Baksh, Stefania Bargagna, Nicole T. Baumer, Ana Claudia Brandão, Angelo Carfi, Maria Carmona-Iragui, Brain Allen Chicoine, Sujay Ghosh, Monica Lakhanpaul, Coral Manso, Miguel-Angel Mayer, Maria del Carmen Ortega, Diego Real de Asua, Anne-Sophie Rebillat, Lauren Ashley Russell, Giuseppina Sgandurra, Diletta Valentini, Stephanie L Sherman, Andre Strydom
medRxiv 2020.11.03.20225359; doi: https://doi.org/10.1101/2020.11.03.20225359
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area